Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus

Pseudovirion-based neutralization assay is considered the gold standard method for evaluating the immune response to human papillomavirus (HPV) vaccines. In this study, we developed a multicolor neutralization assay to simultaneously detect the neutralizing antibodies against different HPV types. Fl...

Full description

Bibliographic Details
Main Authors:	Jianhui Nie, Yangyang Liu, Weijin Huang, Youchun Wang
Format:	Article
Language:	English
Published:	MDPI AG 2016-04-01
Series:	Viruses
Subjects:	human papillomavirus HPV vaccine FluoroSpot multiplex immunoassay
Online Access:	http://www.mdpi.com/1999-4915/8/4/107

Similar Items

Diagnostic accuracy of Mycobacterium tuberculosis-specific triple-color FluoroSpot assay in differentiating tuberculosis infection status in febrile patients with suspected tuberculosis
by: Lifan Zhang, et al.
Published: (2025-01-01)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
by: Sylvia Janetzki, et al.
Published: (2014-11-01)

The Importance of Monitoring Antigen-Specific Memory B Cells, and How ImmunoSpot Assays Are Suitable for This Task
by: Greg A. Kirchenbaum, et al.
Published: (2025-02-01)

Memory B-Cell Responses Against Merozoite Antigens After Acute Plasmodium falciparum Malaria, Assessed Over One Year Using a Novel Multiplexed FluoroSpot Assay
by: Peter Jahnmatz, et al.
Published: (2021-02-01)

Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study
by: Lifan Zhang, et al.
Published: (2021-07-01)

T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern
by: Hila Cohen, et al.
Published: (2022-02-01)

Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection
by: Carla Wolf, et al.
Published: (2022-11-01)

Triple Cytokine FluoroSpot Analysis of Human Antigen-Specific IFN-γ, IL-17A and IL-22 Responses
by: Tomas Dillenbeck, et al.
Published: (2014-11-01)

Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
by: Zheng Quan Toh, et al.
Published: (2020-10-01)

Comparison of ELISpot and FluoroSpot in the Analysis of Swine Flu-Specific IgG and IgA Secretion by in Vivo Activated Human B Cells
by: Bernt Axelsson, et al.
Published: (2012-04-01)

Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay
by: Henriette Hoffmann-Veltung, et al.
Published: (2022-07-01)

Construction and evaluation of human papillomavirus genotype 18 pseudovirions
by: H Sharifi, et al.
Published: (2015-11-01)

Simultaneous Detection of Antigen-Specific IgG- and IgM-Secreting Cells with a B Cell Fluorospot Assay
by: M. Anthony Moody, et al.
Published: (2012-03-01)

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types
by: Katrina M. Nolan, et al.
Published: (2023-04-01)

Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population
by: Trisha L. Amboree, et al.
Published: (2022-08-01)

Comparison of antibody responses to human papillomavirus vaccination as measured by three assays
by: Hilary Ann Robbins, et al.
Published: (2014-01-01)

Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review
by: Meng Wang, et al.
Published: (2024-12-01)

Multiplexed High-Throughput Serological Assay for Human Enteroviruses
by: Niila V. V. Saarinen, et al.
Published: (2020-06-01)

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review
by: Biyuan Xing, et al.
Published: (2021-02-01)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
by: Darron R. Brown, et al.
Published: (2022-06-01)

Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance
by: Karly S. Louie, et al.
Published: (2018-06-01)

Maternal human papillomavirus infections at mid-pregnancy and delivery in a Scandinavian mother–child cohort study
by: Magdalena R. Værnesbranden, et al.
Published: (2021-07-01)

Importance of peniscopy, oncologic cytology and histopathology in the diagnosis of penile infection by human papillomavirus
by: Sérgio Mancini Nicolau, et al.

Human papillomavirus vaccination at the first opportunity: An overview
by: Robert A. Bednarczyk, et al.
Published: (2023-01-01)

Involvement of Human Papillomaviruses in Cervical Cancer
by: Xuelian Wang, et al.
Published: (2018-11-01)

Secondary school girls' knowledge and practice on human papillomavirus (HPV), cervical cancer and human papillomavirus (HPV) vaccination in Kuantan, Pahang, Malaysia
by: Khin Thandar Aung, et al.
Published: (2017-01-01)

Cervical cytology and human papillomavirus among asymptomatic healthy volunteers in Vientiane, Lao PDR
by: Reika Takamatsu, et al.
Published: (2017-12-01)

Human papillomavirus infection and disease in men: Impact of HIV
by: Sinead Delany-Moretlwe, et al.
Published: (2013-11-01)

PAPILLOMAVIRUSES: HPV AS THE ETIOLOGICAL FACTOR OF HEAD AND NECK CANCERS
by: Michał Wiciński, Kamil Leis, et al.
Published: (2018-06-01)

Molecular Epidemiology of Human Papillomavirus
by: Talia Hoory, et al.
Published: (2008-03-01)

Cervical Cancer and Human Papillomavirus Awareness among Women in Saudi Arabia
by: Khalid Akkour, et al.
Published: (2021-12-01)

Geographical disparities in human papillomavirus herd protection
by: Abbey B. Berenson, et al.
Published: (2020-07-01)

Evaluation of knowledge and attitudes of the faculty of medicine students about human papillomavirus infections, related cancers, and human papillomavirus vaccines
by: Zührenur Yağan, et al.
Published: (2023-04-01)

The prevalence of human papillomavirus in pediatric tonsils: a systematic review of the literature
by: Monika Wojtera, et al.
Published: (2018-01-01)

Human Papillomavirus-Associated Cancers in Georgia, 2008-2012
by: Irene Solomon, et al.
Published: (2016-04-01)

Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
by: Steffi Silling, et al.
Published: (2014-01-01)

Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile
by: Eizuru Yoshito, et al.
Published: (2011-06-01)

High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population
by: Jazbet Gallegos-Bolaños, et al.
Published: (2017-08-01)

High-throughput malaria serosurveillance using a one-step multiplex bead assay
by: Eric Rogier, et al.
Published: (2019-12-01)

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
by: Nina Körber, et al.
Published: (2023-03-01)